Vaccination against hepatitis B among prisoners in Iran: Accelerated vs. classic vaccination

Health Policy

Volumn 100, Issue 2-3, 2011, Pages 297-304

  Asli, Ali Asghar Zolghadr ^a   Moghadami, Mohsen ^b   Zamiri, Nima ^b   Tolide ei, Hamid Reza ^c   Heydari, Seyyed Taghi ^b   Alavian, Seyed Moayed ^d   Lankarani, Kamran B ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Accelerated vaccination; Compliance; Hepatitis B virus; Immunization; Seroprotection

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; HEPATITIS B; HUMAN; IMMUNITY; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; PRISONER; VACCINATION;

ADULT; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; IRAN; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PRISONERS; TIME FACTORS;

EID: 79954850723     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.12.007     Document Type: Article

References (35)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 2004, 11(March (2)):97-107.
2. Custer B., Sullivan S.D., Hazlet T.K., Iloeje U., Veenstra D.L., Kowdley K.V. Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology 2004, 38(November-December (10 Suppl. 3)):S158-S168.
3. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. International Journal of Epidemiology 2005, 34(December (6)):1329-1339.
4. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006, 45(October (4)):529L 538.
5. World Health Organization. Hepatitis B fact sheet number 204, 2008. Available at: ; [accessed 12/16/08]. http://www.who.int/mediacentre/factsheets/fs204/en/.
6. Hauri A.M., Armstrong G.L., Hutin Y.J. The global burden of disease attributable to contaminated injections given in health care settings. International Journal STD and AIDS 2004, 15(January (1)):7-16.
7. Alavian S., Hajarizadeh B., Ahmadzad-Asl M., Kabir A., Bagheri-Lankarani K. Hepatitis B virus infection in Iran: a systematic review. Hepatitis Monthly 2008, 8(4):14.
8. Alavian S.M., Zamiri N., Gooya M.M., Tehrani A., Heydari S.T., Lankarani K.B. Hepatitis B vaccination of adolescents: a report on the national program in Iran. Journal of Public Health Policy 2010, 31(December (4)):478-493.
9. Merat S., Rezvan H., Nouraie M., Jamali A., Assari S., Abolghasemi H., et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Archives of Iranian Medicine 2009, 12(May (3)):225-231.
10. Bayas J.M., Bruguera M., Martin V., Vidal J., Rodes J., Salleras L.Y. Hepatitis B vaccination in prisons: the Catalonian experience. Vaccine 1993, 11(November (14)):1441-1444.
11. Adjei A.A., Armah H.B., Gbagbo F., Ampofo W.K., Boamah I., Adu-Gyamfi C., et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infectious Diseases 2008, 8:33.
12. Mast E.E., Weinbaum C.M., Fiore A.E., Alter M.J., Bell B.P., Finelli L., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP). Part II. Immunization of adults. MMWR Recommendations and Report 2006, 55(December (8 RR-16)):1-33. [quiz CE1-4].
13. Hepatitis B outbreak in a state correctional facility, 2000. Morbidity and Mortality Weekly Report 2001, 50(June (25)):529-532.
14. Stief A.C., Martins R.M., Andrade S.M., Pompilio M.A., Fernandes S.M., Murat P.G., et al. Seroprevalence of hepatitis B virus infection and associated factors among prison inmates in state of Mato Grosso do Sul, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2010, 43(October (5)):512-515.
15. SeyedAlinaghi S.A., Kheirandish P., Karami N., Salem S., Shirzad H., Jahani M.R., et al. High prevalence of chronic hepatitis B infection among injection drug users in Iran: the need to increase vaccination of adults at risk. Acta Medica Iran 2010, 48(January-February (1)):58-60.
16. Khani M. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Archives of Iranian Medicine 2003, 6(1):1-4.
17. Zuckerman J.N. The place of accelerated schedules for hepatitis A and B vaccinations. Drugs 2003, 63(17):1779-1784.
18. Bock H.L., Loscher T., Scheiermann N., Baumgarten R., Wiese M., Dutz W., et al. Accelerated Schedule for Hepatitis B Immunization. Journal of Travel Medicine 1995, 2(Dec (4)):213-217.
19. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research edition) 340:c332.
20. Awofeso N. Hepatitis B vaccination in prisons. Bulletin of the World Health Organization 2002, 80(7):569-574.
21. Chen W., Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database of Systematic Reviews (Online) 2005, (4). CD000100.
22. Rich J.D., Ching C.G., Lally M.A., Gaitanis M.M., Schwartzapfel B., Charuvastra A., et al. A review of the case for hepatitis B vaccination of high-risk adults. The American Journal of Medicine 2003, 114(March (4)):316-318.
23. Goldstein S.T., Alter M.J., Williams I.T., Moyer L.A., Judson F.N., Mottram K., et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. The Journal of Infectious Diseases 2002, 185(March (6)):713-719.
24. Sutton A.J., Gay N.J., Edmunds W.J., Gill O.N. Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population. Epidemiology and Infection 2008, 136(December (12)):1644-1649.
25. Weild A.R., Gill O.N., Bennett D., Livingstone S.J., Parry J.V., Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Communicable Disease and Public Health/PHLS 2000, 3(June (2)):121-126.
26. Sutton A.J., Gay N.J., Edmunds W.J., Andrews N.J., Hope V.D., Gilbert R.L., et al. Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection 2006, 134(April (2)):231-242.
27. Kane M., Clements J., Hule D., Hepatitis B. Disease control priorities in developing countries 1999, 321-330. Oxford University Press, New York. D.T. Jamison (Ed.).
28. Christensen P.B. Hepatitis immunization in prison. Proceedings of the fourth European seminar on HIV and hepatitis in prison 2001.
29. Nyamathi A.M., Sinha K., Saab S., Marfisee M., Greengold B., Leake B., et al. Feasibility of completing an accelerated vaccine series for homeless adults. Journal of Viral Hepatitis 2009, 16(September (9)):666-673.
30. Kallinowski B., Jilg W., Buchholz L., Stremmel W., Engler S. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Zeitschrift fur Gastroenterologie 2003, 41(October (10)):983-990.
31. Nothdurft H.D., Dietrich M., Zuckerman J.N., Knobloch J., Kern P., Vollmar J., et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine 2002, 20(January (7-8)):1157-1162.
32. Christensen P.B., Fisker N., Krarup H.B., Liebert E., Jaroslavtsev N., Christensen K., et al. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine 2004, 22(September (29-30)):3897-3901.
33. Joines R.W., Blatter M., Abraham B., Xie F., De Clercq N., Baine Y., et al. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 2001, 19(September (32)):4710-4719.
34. Bosnak M., Dikici B., Bosnak V., Haspolat K. Accelerated hepatitis B vaccination schedule in childhood. Pediatrics International 2002, 44(December (6)):663-665.
35. Tarhan M.O., Aker A.I., Sipahi O.R., Kardes G., Biberoglu K. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination. Medical Science Monitor 2006, 12(November (11)):CR467-CR470.